Open Access

Evaluating cardiovascular risk reduction with glucagon-like peptide-1 receptor agonists.

Presentation

About the speaker

Doctor Michael Lehrke

RWTH University Hospital Aachen, Aachen (Germany)
0 follower

4 more presentations in this session

Welcome and introduction.

Speaker: Professor K. Connelly (Toronto, CA)

Thumbnail

Highlighting cardiovascular benefits of glucagon-like peptide-1 receptor agonists.

Speaker: Professor K. Connelly (Toronto, CA)

Thumbnail

Exploring the gap between data and clinical practice.

Speaker: Assistant Professor N. Pagidipati (Durham, US)

Thumbnail

Panel discussion.

Speaker: Professor K. Connelly (Toronto, CA) Doctor M. Lehrke (Aachen, DE) Assistant Professor N. Pagidipati (Durham, US)

Thumbnail

Access the full session

Discussing clinical implications of glucagon-like peptide-1 receptor agonists

Speakers: Doctor M. Lehrke, Professor K. Connelly, Professor K. Connelly, Assistant Professor N. Pagidipati, Professor K. Connelly...
Thumbnail

About the event

Image

ESC CONGRESS 2020 - The Digital Experience

28 August - 1 September 2020

Sessions Presentations

This platform is supported by

logo Novo Nordisk